Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

92 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Understanding the Burden of Respiratory Syncytial Virus in Older Adults in Latin America: An Expert Perspective on Knowledge Gaps.
Correa RA, Arancibia F, De Ávila Kfouri R, Chebabo A, García G, Gutiérrez Robledo LM, Lopardo G, Nemerovsky J, Pérez CM, Rendon A, Ruiz-Palacios GM, Aggarwal B, Berzanskis A, Cintra O. Correa RA, et al. Among authors: lopardo g. Pulm Ther. 2024 Mar;10(1):1-20. doi: 10.1007/s41030-024-00253-3. Epub 2024 Feb 15. Pulm Ther. 2024. PMID: 38358618 Free PMC article. Review.
Safety and efficacy of doravirine as first-line therapy in adults with HIV-1: week 192 results from the open-label extensions of the DRIVE-FORWARD and DRIVE-AHEAD phase 3 trials.
Orkin C, Molina JM, Cahn P, Lombaard J, Supparatpinyo K, Kumar S, Campbell H, Wan H, Teal V, Jin Xu Z, Asante-Appiah E, Sklar P, Teppler H, Lahoulou R; DRIVE-FORWARD and DRIVE-AHEAD collaborators. Orkin C, et al. Lancet HIV. 2024 Feb;11(2):e75-e85. doi: 10.1016/S2352-3018(23)00258-8. Epub 2023 Dec 20. Lancet HIV. 2024. PMID: 38141637 Clinical Trial.
[Comparative analysis of clinical characteristics, evolution and mortality of hospitalized patients with COVID-19 during the first and second wave of the pandemic (ECCOVID Study)].
Córdova E, Mykietiuk A, De Vedia L, Bacelar B, Cáceres MF, Nemirovsky C, Contreras R, Alzogaray MF, Nannini E, Consalvo MF, Soler Puy L, Scapellato PG, Barcelona L, Golikow ML, Piñeiro MF, Miño HJ, Cabral M, Lamponi Tappata L, Lopardo G, Sued O, Stryjewski ME; Grupo ECCOVID-SADI. Córdova E, et al. Among authors: lopardo g. Medicina (B Aires). 2023;83(4):551-557. Medicina (B Aires). 2023. PMID: 37582129 Free article. Spanish.
The global challenges of the long COVID-19 in adults and children.
Rodriguez-Morales AJ, Lopez-Echeverri MC, Perez-Raga MF, Quintero-Romero V, Valencia-Gallego V, Galindo-Herrera N, López-Alzate S, Sánchez-Vinasco JD, Gutiérrez-Vargas JJ, Mayta-Tristan P, Husni R, Moghnieh R, Stephan J, Faour W, Tawil S, Barakat H, Chaaban T, Megarbane A, Rizk Y, Sakr R, Escalera-Antezana JP, Alvarado-Arnez LE, Bonilla-Aldana DK, Camacho-Moreno G, Mendoza H, Rodriguez-Sabogal IA, Millán-Oñate J, Lopardo G, Barbosa AN, Cimerman S, Chaves TDSS, Orduna T, Lloveras S, Rodriguez-Morales AG, Thormann M, Zambrano PG, Perez C, Sandoval N, Zambrano L, Alvarez-Moreno CA, Chacon-Cruz E, Villamil-Gomez WE, Benites-Zapata V, Savio-Larriera E, Cardona-Ospina JA, Risquez A, Forero-Peña DA, Henao-Martínez AF, Sah R, Barboza JJ, León-Figueroa DA, Acosta-España JD, Carrero-Gonzalez CM, Al-Tawfiq JA, Rabaan AA, Leblebicioglu H, Gonzales-Zamora JA, Ulloa-Gutiérrez R. Rodriguez-Morales AJ, et al. Among authors: lopardo g. Travel Med Infect Dis. 2023 Jul-Aug;54:102606. doi: 10.1016/j.tmaid.2023.102606. Epub 2023 Jun 8. Travel Med Infect Dis. 2023. PMID: 37295581 Free PMC article. No abstract available.
Safety and effectiveness of RBD-specific polyclonal equine F(ab´)2 fragments for the treatment of hospitalized patients with severe Covid-19 disease: A retrospective cohort study.
Farizano Salazar DH, Achinelli F, Colonna M, Pérez L, Giménez AA, Ojeda MA, Miranda Puente SN, Sánchez Negrette L, Cañete F, Martelotte Ibarra OI, Sanguineti S, Spatz L, Goldbaum FA, Massa C, Rivas M, Pichel M, Hiriart Y, Zylberman V, Gallego S, Konigheim B, Fernández F, Deprati M, Roubicek I, Giunta DH, Nannini E, Lopardo G, Belloso WH; EPIC Study Group. Farizano Salazar DH, et al. Among authors: lopardo g. PLoS One. 2022 Sep 26;17(9):e0274796. doi: 10.1371/journal.pone.0274796. eCollection 2022. PLoS One. 2022. PMID: 36155545 Free PMC article.
Monkeypox: Another Sexually Transmitted Infection?
Rodriguez-Morales AJ, Lopardo G. Rodriguez-Morales AJ, et al. Among authors: lopardo g. Pathogens. 2022 Jun 21;11(7):713. doi: 10.3390/pathogens11070713. Pathogens. 2022. PMID: 35889960 Free PMC article.
Latin America: Situation and preparedness facing the multi-country human monkeypox outbreak.
Rodriguez-Morales AJ, Lopardo G, Verbanaz S, Orduna T, Lloveras S, Azeñas-Burgoa JM, Escalera-Antezana JP, Alvarado-Arnez LE, Barbosa AN, Diaz-Quijano F, Cimerman S, Chaves TDSS, Rodriguez-Morales AG, Perret C, Méndez CA, Riera JA, Bonilla-Aldana DK, Camacho-Moreno G, Mendoza H, Rodriguez-Sabogal IA, Oñate J, Escobedo AA, Thormann M, Roque Y, Zambrano PG, Carrero Y, Sandoval N, Zambrano L, Franco-Paredes C, Chacon-Cruz E, Lopez-Delgado I, Cuadra-Sánchez C, Pachar-Flores M, Correa R, Rodriguez-Enciso HD, Rotela-Fisch V, Maquera-Afaray J, Herrera-Añazco P, Benites-Zapata V, Savio-Larriera E, Ramírez JD, Paniz-Mondolfi A, Risquez A, Forero-Peña DA, Torres JR, Suarez JA. Rodriguez-Morales AJ, et al. Among authors: lopardo g. Lancet Reg Health Am. 2022 Sep;13:100318. doi: 10.1016/j.lana.2022.100318. Epub 2022 Jul 6. Lancet Reg Health Am. 2022. PMID: 35813461 Free PMC article. No abstract available.
Final efficacy analysis, interim safety analysis, and immunogenicity of a single dose of recombinant novel coronavirus vaccine (adenovirus type 5 vector) in adults 18 years and older: an international, multicentre, randomised, double-blinded, placebo-controlled phase 3 trial.
Halperin SA, Ye L, MacKinnon-Cameron D, Smith B, Cahn PE, Ruiz-Palacios GM, Ikram A, Lanas F, Lourdes Guerrero M, Muñoz Navarro SR, Sued O, Lioznov DA, Dzutseva V, Parveen G, Zhu F, Leppan L, Langley JM, Barreto L, Gou J, Zhu T; CanSino COVID-19 Global Efficacy Study Group. Halperin SA, et al. Lancet. 2022 Jan 15;399(10321):237-248. doi: 10.1016/S0140-6736(21)02753-7. Epub 2021 Dec 23. Lancet. 2022. PMID: 34953526 Free PMC article. Clinical Trial.
92 results